MedTrace Logo

Uses of Irradiated Human Amniotic Membrane in the Treatment of Dystrophic Epidermolysis Bullosa Patients

NCT03942250 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2023-09-21

No results posted yet for this study

Summary

To evaluate the effect of human amniotic membrane as a weekly dressing on chronic wounds in Epidermolysis Bullosa (EB) patients.

Conditions

  • Epidermolysis Bullosa
  • Chronic Skin Ulcer

Interventions

BIOLOGICAL

REGE pro dressing

REGE pro is a dressing of dried human amniotic membrane sterilized by gamma radiation

Sponsors & Collaborators

  • Waleed Nemr,Egyptian Atomic Energy Authority

    collaborator UNKNOWN

  • Egyptian Atomic Energy Authority

    lead OTHER_GOV

Principal Investigators

  • Nashwa K Radwan, PhD · NATIONAL CENTER FOR RADIATION RESEARCH AND TECHNOLOGY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2019-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03942250 on ClinicalTrials.gov